Insulet
PODD
#1922
Rank
NZ$18.77 B
Marketcap
NZ$270.75
Share price
2.40%
Change (1 day)
-50.64%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): NZ$0.96 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$3.05 Billion. In 2025 the company made an earning of NZ$0.70 Billion, an increase over its 2024 earnings that were of NZ$0.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.96 B35.75%
2025 NZ$0.70 B16.3%
2024 NZ$0.60 B36.76%
2023 NZ$0.44 B481.9%
2022 NZ$76.51 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$97.46 M18.51%
2019 NZ$82.24 M41.16%
2018 NZ$58.26 M-711.95%
2017 -NZ$9.53 Million-56.85%
2016 -NZ$22.07 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$65.11 Million31.04%
2013 -NZ$49.69 Million-21.96%
2012 -NZ$63.67 Million
2010 -NZ$60.73 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$95.6 Million209.75%
2006 -NZ$30.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.52 B 4,635.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.44 B 1,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$13.01 B 1,224.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$59.64 B 5,970.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.11 Billion-111.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.14 B-85.03%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$2.29 B 134.01%๐Ÿ‡บ๐Ÿ‡ธ USA